P1‐060: Validation of the apathy scale for institutionalized dementia patients: The APADEM scale | Zendy

AgüeraOrtiz Luis | Zendy; CruzOrduña Isabel | Zendy; RamosGarcía Isabel | Zendy; ValentíSoler Meritxell | Zendy; GilRuiz Nuria | Zendy; Ricardo Osorio | Zendy; MartinezMartin Pablo | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Premium

P1‐060: Validation of the apathy scale for institutionalized dementia patients: The APADEM scale

Author(s) -

AgüeraOrtiz Luis,

CruzOrduña Isabel,

RamosGarcía Isabel,

ValentíSoler Meritxell,

GilRuiz Nuria,

Ricardo Osorio,

MartinezMartin Pablo

Publication year - 2012

Publication title -

alzheimer's and dementia

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 6.713

H-Index - 118

eISSN - 1552-5279

pISSN - 1552-5260

DOI - 10.1016/j.jalz.2012.05.336

Subject(s) - apathy , cronbach's alpha , dementia , dementia with lewy bodies , psychology , ceiling effect , clinical dementia rating , geriatric depression scale , rating scale , clinical psychology , population , psychiatry , psychometrics , medicine , cognition , disease , developmental psychology , depressive symptoms , pathology , alternative medicine , environmental health

Patients and methods: 100 elderly, institutionalized patients (90% female) with diagnosis of probable Alzheimer Disease (AD) ( 57%), possible AD (13%), AD + cerebral vascular disease (17%), Lewy bodies Dementia (11%) and Parkinson associated to dementia (2%), covering all stages of the disease according to the Global Deterioration Scale (GDS) and Clinical Dementia Rating (CDR). Assessments: Apathy Inventory (AI), Neuropsychiatric Inventory (NPI), Cornell scale for depression, and the tested scale APADEM-NH. Re-test was carried out in 50 patients and inter-rater reliability was explored also in 50 patients. The following attributes were analyzed: feasibility and acceptability, reliability, validity, and measurement precision.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here

Accelerating Research